Cisplatin induced intermediate filament reorganization and altered mitochondrial function in 3T3 cells and drug-sensitive and -resistant walker 256 cells

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 69-78

  Evans, Robert M ^a   Simpkins, Henry ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin toxicity; Intermediate filaments; Mitochondria

Indexed keywords

CISPLATIN; INTERMEDIATE FILAMENT PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SENSITIVITY; FLUORESCENCE; INTERMEDIATE FILAMENT; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; WALKER CARCINOMA;

ANIMALIA;

EID: 0031773714     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4250     Document Type: Article

References (68)

1. Rosencweig, M., Van Hoff, D. D., Slavik, M., and Muggia, R. M. (1977). Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann. Intern. Med. 86, 803-812.
2. Brenner, J., Magrill, E. B., Sordillo, P. P., Cheng, E. W., and Yagoda, A. (1982). Phase III trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma. Cancer 50, 2031-2033.
3. Ensley, J. R., Jacobs, J. R., Weaver, A., Kinzie, J., Crissman, J., Kish, J. A., Cummings, G., and Al-Sarraf, M. (1984). Correlation between response to cisplatin-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54, 811-814.
4. Whitehead, R. P., Rosenbaum, P. R., and Carbone, P. P. (1984). Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma. Cancer Treat. Rep. 68, 771-773.
5. Feun, L. G., Wallace, S., Stewart, D. J., Chuang, V. P., Yung, W. A., Leavens, W. A., Burgess, M. E., Savaraj, A., Benjamin, R. S., Young, S. E., Tang, R. A., Hanel, S., Marglit, G., and Fields, W. S. (1984). Intracarotid infusion of cis-diamminedi-chloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54, 794-799.
6. Carlson, J. A., Day, T. G., Allegra, J. C., Woodcock, T. M., Greenberg, R. A., and Masterson, B. (1994). methyl-CCNU, doxorubicin, and cis-diaminedichloroplatinum (II) in the management of recurrent and metastatic squamous carcinoma of the cervix. Cancer 54, 211-214.
7. Roberts, J. J., Knox, R. J., Friedlos, F., and Lydall, D. A. (1986). In "Biochemical Mechanisms of Platinum Antitumor Drugs" (C. H. McBrien and T. F. Slater, Eds.), pp. 29-64, IRL Press, Oxford, UK.
8. Strandberg, M., Bresnick, E., and Eastman, A. (1982). The significance of DNA cross-linking to cis-diamminedichloroplatinum (II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Chem. Biol. Interact. 39, 169-180.
9. Rawlings, C. J., and Roberts, J. J. (1986). The unique sensitivity of Walker rat tumor cells to difunctional agents is associated with a failure to recover from inhibition of DNA synthesis and increased chromosome damage. Mutat. Res. 166, 157-169.
10. Meijer, S., Sleijfer, D., ThMulder, N. A., Sluitere, W. J., Marrink, W. J., Koops, H. S., Brouwers, T. M., Oldhoff, J., Van Der Hem, G. K., and Mandema, E. (1983). Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer 51, 2035-2040.
11. Sharma, R. P., and Edwards, I. R. (1983). Cis-platinum: Subcellular distribution and binding to cytosolic ligands. Biochem. Pharmacol. 32, 2665-2669.
12. Simpkins, H., Figliomeni, M., and Rosen, M. (1988). The interaction of platinum and anthrapyrazole antitumor drugs with mouse thymocytes studied by terbium fluorescence. Biochim. Biophys. Acta 972, 25-32.
13. Rosen, M., Figliomeni, M., and Simpkins, H. (1992). The interaction of platinum antitumor drugs with mouse liver mitochondria. Int. J. Exp. Pathol. 73, 61-74.
14. Molinari, A., Calcabrini, A., Crateri, P., and Arancia, G. (1990). Interaction of anthracycline antibiotics with cytoskeletal components of cultured carcinoma cells (CG5). Exp. Mol. Pathol. 53, 11-33.
15. Bauman, P. A., Dalton, W. S., Anderson, J. M., and Cress, A. E. (1994). Expression of cytokeratin confers multiple drug resistance. Proc. Natl. Acad. Sci. USA 91, 5311-5314.
16. Parekh, H., and Simpkins, H. (1995). The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer Res. 55, 5203-5206.
17. Cress, A. E., and Dalton, W. S. (1996). Multiple drug resistance and intermediate filaments. Cancer Metastasis Rev. 15, 499-506.
18. Fuchs, E., and Weber, K. (1994). Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63, 345-382.
19. Klymkowsky, M. W., and Evans, R. M. (1995). In "Principals of Medical Biology" (E. E. Bittar and N. Bittar, Eds.), Vol. 2, pp. 147-176, JAI Press, Greenwich, CT.
20. Fuchs, E., and Cleveland, D. W. (1998). A structural scaffolding of intermediate filaments in health and disease. Science 279, 514-519.
21. Omary, M. B., and Ku, N.-O. (1997). Intermediate filament proteins of the liver: emerging disease association and functions. Hepatology 25, 1043-1048.
22. Ku, N.-O., Michie, S. A., Soetikino, R. M., Resurreccion, E. Z., Broome, R. L., Oshima, R. G., and Omary, M. B. (1996). Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J. Clin. Invest. 98, 1034-1046.
23. Franke, W. W., Grund, C., Osborn, M., and Weber, K. (1978). The intermediate-sized filaments in rat kangaroo PtK2 cells. I. Morphology in-situ. Cytobiologie 17, 365-391.
24. Moscinski, L. M., and Evans, R. M. (1987). In "International Symposium on the Cytoskeleton in Differentiation and Development" (J. Arechaga and R. Maccioni, Eds.), pp. 267-279, ICSU Press, London.
25. Johnson, L. V., Walsh, M. L., Bockus, B. J., and Chen, L. B. (1981). Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88, 526-535.
26. Zackroff, R. V., and Goldman, R. D. (1979). In vitro assembly of intermediate filaments from baby hamster kidney (BHK-21) cells. Proc. Natl. Acad. Sci. USA 76, 6626-6230.
27. O'Farrell, P. H. (1975). High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021.
28. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
29. Sklar, M. D. (1988). Increased resistance to cis-diamminedi-chloroplatinum (II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res. 48, 793-797.
30. Klymkowsky, M. W. (1988). Metabolic inhibitors and intermediate filament organization in human fibroblasts. Exp. Cell Res. 174, 282-290.
31. Bramwell, V. H. C., Crowther, D., O'Malley, S., Swindell, R., Johnson, R., Cooper, E. H., Thatcher, N., and Howell, A. (1985). Activity of JM9 in advanced ovarian cancer. A phase I-II trial. Cancer Treat. Rep. 69, 409-416.
32. Hortobagyi, G. N., Frye, D., Holmes, F. A., Huy, V., Fraschini, G., and Buzdar, A. V. (1987). Phase II study of iproplatin in metastatic breast carcinoma. Cancer Treat. Rep. 71, 1193-1196.
33. Howle, J. A., and Gale, G. R. (1970). Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochem. Pharmacol. 19, 2757-2762.
34. Harder, H. C., and Rosenberg, B. (1970). Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int. J. Cancer 6, 207-216.
35. Mauro, B., and Borens, M. (1982). Reorganization of HeLa cytoskeleton induced by an uncoupler of oxidative phosphorylation. Nature 295, 334-336.
36. Johnson, L. V., Walsh, M. L., and Chen, L. B. (1980). Localization of mitochondria in living cells with rhodamine 123. Proc. Natl Acad. Sci. USA 77, 990-994.
37. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B. (1985). Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 260, 13844-13850.
38. Mose-Larsen, P., Bravo, R., Fey, S. J., Small, J. V., and Celis, J. E. (1982). Putative association of mitochondria with a subpopulation of intermediate-sized filaments in cultured human skin fibroblasts. Cell 31, 681-692.
39. Summerhayes, I. C., Wong, D., and Chen, L. B. (1983). Effects of microtubules and intermediate filaments on mitochondrial distribution. J. Cell Sci. 61, 87-105.
40. Toh, B. H., Lolait, S. J., Mathy, J. P., and Baum, R. (1980). Association of mitochondria with intermediate filaments and of polyribosomes with cytoplasmic actin. Cell Tissue Res. 211, 163-169.
41. Tokuyasu, K. T., Maher, P. A., Dutton, A. H., and Singer, S. J. (1985). Intermediate filaments in skeletal and cardiac muscle tissue in embryonic and adult chicken. Ann. N.Y. Acad. Sci. 455, 200-211.
42. Klymkowsky, M. W., Bachant, J. B., and Domingo, A. (1989). Functions of intermediate filaments. Cell Motil. Cytoskeleton 14, 309-331.
43. Parekh, H., and Simpkins, H. (1996). Cross-resistance and collaterial sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemother. Pharm. 37, 457-462.
44. Knox, R. J., Lydall, D. A., Friedlos, F., Basham, C., and Roberts, J. J. (1987). The effect of monofunctional or difunctional platinum adducts and of various other associated DNA damage on the expression of transfected DNA in mammalian cell lines sensitive or resistant to difunctional agents. Biochim. Biophys. Acta 908, 214-223.
45. Simpkins, H., Lehman, J. M., Mazurkiewicz, J. E., and Davis, B. H. (1991). A morphological and phenotypic analysis of Walker 256 cells. Cancer Res. 51, 1334-1338.
46. 31P NMR spectroscopy. Biochem. Biophys. Res. Commun. 183, 114-120.
47. Sharpe, A. H., Chen, L. B., Murphy, J. R., and Fields, B. N. (1980). Specific disruption of vimentin filament organization in monkey kidney CV-1 cells by diphtheria toxin, exotoxin A, and cycloheximide. Proc. Natl. Acad. Sci. USA 77, 7267-7271.
48. Zieve, G. W., and Roemer, E. J. (1988). Cordycepin rapidly collapses the intermediate filament networks into juxtanuclear caps in fibroblasts and epidermal cells. Exp. Cell Res. 177, 19-26.
49. Eckert, B. S. (1985). Alteration of intermediate filament distribution in PtK1 cells by acrylamide. Eur. J. Cell Biol. 37, 169-174.
50. Troncoso, J. C., Sternberger, N. H., Sternberger, L. A., Hoffman, P. N., and Price, D. L. (1986). Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain Res. 364, 295-300.
51. Leterrier, J. F., Langui, D., Probst, A., and Ulrich, J. (1992). A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J. Neurochem. 58, 2060-2070.
52. Durham, H. D. (1988). Aggregation of intermediate filaments by 2,5-hexanedione: Comparison of effects on neurofilaments, GFAP-filaments and vimentin filaments in dissociated cultures of mouse spinal cord-dorsal root ganglia. J. Neuropathol. Exp. Neurol. 47, 432-442.
53. Durham, H. D., Pena, S. D. J., and Carpenter, S. (1983). The neurotoxins 2,5 hexanedione and acrylamide promote aggregation of intermediate filaments in cultured fibroblasts. Muscle Nerve 6, 631-637.
54. Durham, H. D., Pena, S. D. J., and Ecobichon, D. J. (1988). Hexahydrocarbon effects on intermediate filament organization in human fibroblasts. Muscle Nerve 11, 160-165.
55. Tuckwell, D. S., Laszlo, L., and Mayer, R. J. (1992). 2,5-hexanedione-induced intermediate filament aggregates contain ubiquitin-protein conjugate immunoreactivity and resemble rosenthal fibres. Neuropathol. Appl. Neurobiol. 18, 593-609.
56. Gold, B. G., and Austin, D. R. (1991). Regulation of aberrant neurofilament phosphorylation in neuronal perikarya. 3. Alterations following single and continuous beta, beta′-iminodipropionitrile administrations. Brain Res. 563, 151-162.
57. Bizzi, A., and Gambetti, P. (1986). Phosphorylation of neurofilaments is altered in aluminum intoxication. Acta Neuropathol. 71, 154-158.
58. Shea, T. B., Beermann, M. L., and Nixon, R. A. (1992). Aluminum alters the electrophoretic properties of neurofilament proteins - Role of phosphorylation state. J. Neurochem. 58, 542-547.
59. Basu, A., Teicher, B. A., and Lazo, J. S. (1990). Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum (II). J. Biol. Chem. 265, 8451-8457.
60. Ando, S., Tanabe, K., Gonda, Y., Sato, C., and Inagaki, M. (1989). Domain and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry 28, 2974-2979.
61. Ciesielski-Treska, J., Ulrich, G., and Aunis, D. (1991). Protein kinase-C-induced redistribution of the cytoskeleton and phosphorylation of vimentin in cultured brain macrophages. J. Neurosci. Res. 29, 362-378.
62. Inagaki, M., Matsuoka, Y., Tsujimura, K., Ando, S., Tokui, T., Takahashi, T., and Inagaki, N. (1996). Dynamic property of intermediate filaments: regulation of phosphorylation. BioEssays 18, 481-487.
63. Laszlo, A., and Bissell, M. (1983). TPA induces simultaneous alterations in the synthesis and organization of vimentin. Exp. Cell Res. 148, 221-234.
64. Welch, W. J., and Mizzer, L. A. (1988). Characterization of the thermotolerant cell. II. Effects on the distribution of heat shock protein 70, intermediate filaments, and small ribonucleoprotein complexes. J. Cell Biol. 106, 1117-1130.
65. Cheng, T. J., and Lai, Y. K. (1994). Transient increase in vimentin phosphorylation and vimentin-hsc70 association in 91 rat brain tumor cells experiencing heat-shock. J. Cell Biochem. 54, 100-109.
66. Lee, Y. C., and Lai, Y. K. (1995). Integrity of intermediate filaments is associated with the development of acquired thermotolerance in 91 rat brain tumor cells. J. Cell Biochem. 57, 150-162.
67. Kamishima, T., Fukuda, T., Yoshiya, N., and Suzuki, T. (1997). Expression and intracellular localization of heat shock proteins in multidrug resistance of a cisplatin resistant human ovarian cancer cell line. Cancer Lett. 716, 205-211.
68. Matsumoto, H., Hayashi, S., Shioura, H., Ohtsuba, T., Ohnishi, T., and Kano, E. (1996). Suppression of heat induced hsp-72 accumulation by cisplatin in human glioblastoma cells. Cancer Lett. 110, 253-257.